Chemed Financial Statements
Chemed Financial Overview
Chemed's market cap is currently ―. The company's EPS TTM is $17.09; its P/E ratio is 27.96; and it has a dividend yield of 0.30%. Chemed is scheduled to report earnings on July 26, 2022, and the estimated EPS forecast is $4.78. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 530.55M | $ 540.98M | $ 538.67M | $ 532.26M | $ 527.36M |
| Gross Profit | $ 194.00M | $ 204.65M | $ 196.50M | $ 181.76M | $ 186.89M |
| EBIT | $ 85.51M | $ 96.94M | $ 95.95M | $ 75.48M | $ 84.04M |
| EBITDA | $ 100.17M | $ 111.29M | $ 110.30M | $ 91.61M | $ 98.27M |
| Net Income Common Stockholders | $ 64.17M | $ 74.63M | $ 72.00M | $ 56.52M | $ 65.40M |
| Balance Sheet | |||||
| Cash, Cash Equivalents and Short-Term Investments | $ 18.16M | $ 28.74M | $ 32.90M | $ 92.12M | $ 112.77M |
| Total Assets | $ 1.31B | $ 1.34B | $ 1.32B | $ 1.38B | $ 1.46B |
| Total Debt | $ 132.12M | $ 134.24M | $ 135.41M | $ 135.68M | $ 142.09M |
| Net Debt | $ 113.96M | $ 105.50M | $ 102.52M | $ 43.56M | $ 29.33M |
| Total Liabilities | $ 639.05M | $ 719.45M | $ 538.41M | $ 513.02M | $ 529.25M |
| Stockholders Equity | $ 623.27M | $ 666.71M | $ 779.72M | $ 801.41M | $ 870.77M |
| Cash Flow | |||||
| Free Cash Flow | $ 88.44M | $ 49.37M | $ 102.12M | $ 9.41M | $ 89.02M |
| Operating Cash Flow | $ 101.09M | $ 63.57M | $ 112.99M | $ 25.32M | $ 106.72M |
| Investing Cash Flow | $ -13.95M | $ -14.04M | $ -10.41M | $ -15.88M | $ -17.42M |
| Financing Cash Flow | $ -101.88M | $ -45.37M | $ -165.96M | $ -127.48M | $ -41.81M |